North America Lipid Panel Testing Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 5,172.71 |
 CAGR |
% |
| Major Markets Players |
North America Lipid Panel Testing Market, By Products & Services (Devices, Kits, and Services), Prescription Mode (Prescription-Based Testing and OTC-Based Testing), Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo lipoproteinemia, Tangier Disease, Atherosclerosis. and Others), End User (Hospitals, Specialty Clinics & Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Pharmacy, Online Sales, and Others) - Industry Trends and Forecast to 2030.
North America Lipid Panel Testing Market Analysis and Insights
The increasing awareness about lipid panel testing North America has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved advancement of processes and techniques also contributes to the rising demand for lipid panel testing.
The North America lipid panel testing market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in the developmental activity for launching novel services and efficient and accurate lipid panel tests in the market. The increasing development in advanced healthcare techniques is further boosting market growth. However, difficulties such as the stringent regulations for the production and commercialization of lipid panel testing products might hamper the growth of the North America lipid panel testing market in the forecast period.
Data Bridge Market Research analyzes that the North America lipid panel testing market is expected to reach the value of USD 5,172.71 million by 2030, at a CAGR of 7.3% during the forecast period.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Products & Services (Devices, Kits, and Services), Prescription Mode (Prescription-Based Testing and OTC-Based Testing), Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo lipoproteinemia, Tangier Disease, Atherosclerosis. and Others), End User (Hospitals, Specialty Clinics & Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Pharmacy, Online Sales, and Others) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
Some major companies dealing in the North America lipid panel testing market are Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Subsidiary of Danaher), and Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.) among others |
North America Lipid Panel Testing Market Definition
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Healthcare providers use lipid panels to assess someone's cardiovascular health by analyzing cholesterol in their blood and to help diagnose other health conditions. The lipid panel assesses the presence of specific fat molecules known as lipids in the blood. It measures multiple substances as a panel test, including several cholesterol-containing molecules. The lipid panel assesses the risk of cardiovascular diseases such as heart disease, heart attack, and stroke in children and adults.
North America Lipid Panel Testing Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- INCREASING PREVALENCE OF CHRONIC DISEASES
A lipid panel is a common blood test used by healthcare providers to monitor and screen the risk of cardiovascular disease and other chronic diseases. The panel includes three measurements of cholesterol and a measurement of triglycerides. While providers & healthcare professionals mostly use lipid panels for screening or monitoring cholesterol levels. Providers sometimes use them as part of the diagnostic process for certain health conditions that can affect your lipid levels, including pancreatitis, chronic kidney disease, and hypothyroidism.
Thus, in conclusion, the rise in the number of chronic diseases such as cardiovascular diseases, chronic kidney disorders, liver diseases, and various other chronic diseases has led to an increase in the demand for lipid profiling with increasing market demand for lipid panel testing kits will drive the growth of the North America lipid panel testing market in coming years.
Restraint
- HIGH COST ASSOCIATED WITH TESTING PANELS
A lipid profile test is a lipid panel, cholesterol profile, or heart risk profile. This is a combination of blood tests that help measure levels of blood fats such as cholesterol and triglycerides. These cholesterol and triglycerides are good and bad types of fat.
The testing panels require a huge cost for the development process. As the concept needs to be locked down, the materials must be sourced, and it is important to consider lead times. Additionally, the process is time-consuming as the device design needs sufficient time to fully mature before entering the market.
Furthermore, any changes that must be re-verified will impact time. The growing advancements in biosensor assay formats and other complementary technologies demanded an effective investment for successful operations and a project risk management plan. Establishing R&D for conducting research entails high costs, leading to expensive devices. Thus, this factor is a major restrain for the North America lipid panel testing market.
Opportunity
GROWTH IN TECHNOLOGICAL ADVANCEMENTS
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Technological developments in lipid panel testing result in additional accuracy, high sensitivity, higher success rate, and newer materials, depending on their use in different lipid panel testing. The commercializing of advanced technology-based lipid panel testing devices and products used for diagnostics and testing procedures has increased consumer demand, which propels the market's demand.
Thus, the technological advancements and development of the lipid panel testing method are expected to drive growth in the North America lipid panel testing market.
Challenge
LACK OF SKILLED & CERTIFIED PROFESSIONALS
The requirement for skilled and certified professionals is a big challenge for lipid panel testing. The demand for lipid panel testing for the diagnosis is increased due to increasing cases of obesity, cardiovascular diseases, and cholesterol North America. However, the fewer skilled professionals in the diagnostic center are hampering the market's growth.
The instruments, methods, and procedures of lipid panel testing diagnosis have been advanced, but there are certain gaps in standardization, equalization, and knowledge. Technicians face technical training gaps related to problems and adapt advanced methods safely to perform procedures efficiently. In lipid panel testing, skilled professionals are highly needed for method development, validation, operation, and troubleshooting.
Post COVID-19 Impact Analysis on North America Lipid Panel Testing Market
Covid-19 made a massive dent in the diagnostics sector with a steep fall in patient volumes since the beginning of 2020. The pandemic developed an eerie sense of fear among people, which eventually impacted hospital/clinic and lab visits. Regular checkups became cumbersome, stressful and time consuming. While the overall diagnostics sector seemed to have suffered a decline, the area of home diagnostics was the silver lining in the new scheme of things.
Recent Developments
- In October 2022, Eurofins Scientific, announced the commencement of the largest European biomonitoring projects for PFAS (polyfluoroalkyl) in blood Antwrep which is commissioned by the Agency for Care and Health of the Flemish Government. This product launch has helped the company in its product portfolio expansion.
- In December 2022, Laboratory Corporation of America Holdings, announced that it had begun the operations at a new, larger anatomic pathology and histology laboratory in Los Angeles. This new operations helped the company in expanding the company’s North America central laboratory capabilities.
North America Lipid Panel Testing Market Scope
North America lipid panel testing market is segmented into five notable segments such as product & services, prescription mode, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
PRODUCT & SERVICES
- DEVICES
- KITS
- SERVICES
On the basis of products & services, the North America lipid panel testing market is segmented into devices, kits and services.
PRESCRIPTION MODE
- PRESCRIPTION-BASED TESTING
- OTC-BASED TESTING
On the basis of prescription mode, the North America lipid panel testing market is segmented into prescription-based testing and OTC-based testing.
APPLICATION
- HYPERLIPIDEMIA
- HYPERTRIGLYCERIDEMIA
- FAMILIAL HYPERCHOLESTEROLEMIA
- HYPO LIPOPROTEINAMIA
- TANGIER DISEASE
- ATHEROSCLEROSIS
- OTHERS
On the basis of application, the North America lipid panel testing market is segmented into hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo lipoproteinemia, tangier disease, atherosclerosis, and others.
END USER
- HOSPITAL
- SPECIALTY CLINICS AND PHYSICIAN OFFICES
- PATHOLOGY LABORATORIES
- DIAGNOSTIC CLINICS
- AMBULATORY SURGICAL CENTERS
- REFERENCE LABORATORIES
- ACADEMIC AND RESEARCH INSTITUTES
- OTHERS
On the basis of end user, the North America lipid panel testing market is segmented into hospitals, specialty clinics & physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.
DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL PHARMACY
- ONLINE SALES
- OTHERS
On the basis of distribution channel, the North America lipid panel testing market is segmented into direct tender, retail pharmacy, online sales, and others.
North America Lipid Panel Testing Market Regional Analysis/Insights
The North America lipid panel testing market is categorized into five notable segments: products and services, prescription mode, application, end user, and distribution channel.
The countries covered in this market report U.S., Canada, and Mexico.
In 2023, U.S is expected to grow due to rise in technological advancement in lipid panel testing market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. In addition, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Lipid Panel Testing Market Share Analysis
North America lipid panel testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, product type lifeline curve. The above data points provided are only related to the company’s focus on the North America lipid panel testing market.
Some major companies dealing in the North America lipid panel testing market are Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Subsidiary of Danaher), and Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.) among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA LIPID PANEL TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS & SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
5.1 KEY PRICING STRATEGY
6 NORTH AMERICA LIPID PANEL TESTING MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN THE U.S
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA
7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS
7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING
7.2 RESTRAINTS
7.2.1 STRICT GOVERNMENT REGULATIONS
7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE
7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING
7.4 CHALLENGES
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS
7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING
8 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES
8.1 OVERVIEW
8.2 SERVICES
8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
8.2.2 TOTAL CHOLESTEROL TEST
8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
8.2.4 TRIGLYCERIDES/ VLDL TEST
8.2.5 NON-HDL CHOLESTEROL TEST
8.2.6 OTHERS
8.3 KITS
8.3.1 STRIPS
8.3.1.1 THREE-ANALYTE TEST STRIPS
8.3.1.2 DUAL-ANALYTE TEST STRIPS
8.3.1.3 SINGLE-ANALYTE TEST STRIPS
8.3.2 LANCETS
8.3.3 CONTROLS
8.3.3.1 MULTI-CHEMISTRY CONTROLS
8.3.3.2 HDL CHOLESTEROL CONTROLS
8.3.3.3 OTHERS
8.3.4 CAPILLARY TUBES
8.4 DEVICES
8.4.1 BY MODALITY
8.4.1.1 STANDALONE
8.4.1.2 HANDHELD
8.4.1.3 PORTABLE
8.4.2 BY TYPE
8.4.2.1 LABORATORY BASED
8.4.2.2 POINT OF CARE BASED
9 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OTC-BASED TESTING
10 NORTH AMERICA LIPID PANEL TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HYPERLIPIDEMIA
10.2.1 TOTAL CHOLESTEROL TEST
10.2.2 TRIGLYCERIDES/ VLDL TEST
10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.2.5 NON-HDL CHOLESTEROL TEST
10.2.6 OTHERS
10.3 HYPERTRIGLYCERIDEMIA
10.3.1 TRIGLYCERIDES/ VLDL TEST
10.3.2 TOTAL CHOLESTEROL TEST
10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.3.5 NON-HDL CHOLESTEROL TEST
10.3.6 OTHERS
10.4 ATHEROSCLEROSIS
10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.4.2 TOTAL CHOLESTEROL TEST
10.4.3 TRIGLYCERIDES/ VLDL TEST
10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.4.5 NON-HDL CHOLESTEROL TEST
10.4.6 OTHERS
10.5 FAMILIAL HYPERCHOLESTEROLEMIA
10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.5.2 TOTAL CHOLESTEROL TEST
10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.5.4 TRIGLYCERIDES/ VLDL TEST
10.5.5 NON-HDL CHOLESTEROL TEST
10.5.6 OTHERS
10.6 HYPO LIPOPROTEINEMIA
10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.6.3 TRIGLYCERIDES/ VLDL TEST
10.6.4 TOTAL CHOLESTEROL TEST
10.6.5 NON-HDL CHOLESTEROL TEST
10.6.6 OTHERS
10.7 TANGIER DISEASE
10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.7.3 TOTAL CHOLESTEROL TEST
10.7.4 TRIGLYCERIDES/ VLDL TEST
10.7.5 NON-HDL CHOLESTEROL TEST
10.7.6 OTHERS
10.8 OTHERS
11 NORTH AMERICA LIPID PANEL TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 PRIVATE
11.2.1.1.1 SERVICES
11.2.1.1.2 KITS
11.2.1.1.3 DEVICES
11.2.1.2 PUBLIC
11.2.1.2.1 SERVICES
11.2.1.2.2 KITS
11.2.1.2.3 DEVICES
11.2.2 BY TIER
11.2.2.1 TIER 1
11.2.2.1.1 SERVICES
11.2.2.1.2 KITS
11.2.2.1.3 DEVICES
11.2.2.2 TIER 2
11.2.2.2.1 SERVICES
11.2.2.2.2 KITS
11.2.2.2.3 DEVICES
11.2.2.3 TIER 3
11.2.2.3.1 SERVICES
11.2.2.3.2 KITS
11.2.2.3.3 DEVICES
11.3 DIAGNOSTIC CLINICS
11.3.1 SERVICES
11.3.2 KITS
11.3.3 DEVICES
11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES
11.4.1 SERVICES
11.4.2 KITS
11.4.3 DEVICES
11.5 REFERENCE LABORATORIES
11.5.1 SERVICES
11.5.2 KITS
11.5.3 DEVICES
11.6 AMBULATORY SURGICAL CENTERS
11.6.1 SERVICES
11.6.2 KITS
11.6.3 DEVICES
11.7 PATHOLOGY LABORATORIES
11.7.1 SERVICES
11.7.2 KITS
11.7.3 DEVICES
11.8 ACADEMIC AND RESEARCH INSTITUTES
11.8.1 SERVICES
11.8.2 KITS
11.8.3 DEVICES
11.9 OTHERS
12 NORTH AMERICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.3.1 HOSPITAL PHARMACIES
12.3.2 DRUG STORES
12.3.3 OTHERS
12.4 ONLINE SALES
12.5 OTHERS
13 NORTH AMERICA LIPID PANEL TESTING MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 NORTH AMERICA LIPID PANEL TESTING MARKET, COMPANY PROFILE
16.1 QUEST DIAGNOSTICS INCORPORATED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 EUROFINS SCIENTIFIC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 F. HOFFMANN-LA ROCHE LTD.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 RANDOX LABORATORIES LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ABBOTT
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 COMPANY SHARE ANALYSIS
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENT
16.7 AWARENESS TECHNOLOGY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ARUP LABORATORIES
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 BOSTON HEART DIAGNOSTICS CORPORATION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CPC DIAGNOSTICS
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 CRODA INTERNATIONAL PLC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 DIATRON
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EKF DIAGNOSTICS
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 EVERLYWELL, INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 ELITECH GROUP
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 HORIBA MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MYLAB BOX
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 NOVA BIOMEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PTS DIAGNOSTICS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SIEMENS HEALTHCARE GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 SINOCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 SD BIOSENSOR, INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENTS
16.26 SPARK DIAGNOSTICS PVT. LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-
TABLE 2 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA LIPID PANEL TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 61 NORTH AMERICA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 NORTH AMERICA DEVICES IN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 67 NORTH AMERICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 NORTH AMERICA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 NORTH AMERICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 91 U.S. LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 92 U.S. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.S. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 94 U.S. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 95 U.S. KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 U.S. STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 U.S. CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 U.S. DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 99 U.S. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.S. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 101 U.S. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 102 U.S. LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 103 U.S. LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 U.S. HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 U.S. HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 U.S. ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 U.S. FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 U.S. HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 U.S. TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 U.S. LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 U.S. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 U.S. PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.S. PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 U.S. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 115 U.S. TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 U.S. TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 U.S. TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 U.S. DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 U.S. SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 U.S. REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 U.S. AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 U.S. PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 123 U.S. ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 124 U.S. LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 U.S. RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 CANADA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 127 CANADA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 CANADA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 129 CANADA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 130 CANADA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 CANADA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 CANADA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 CANADA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 134 CANADA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 CANADA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 136 CANADA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 137 CANADA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 138 CANADA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 CANADA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 CANADA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 CANADA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 CANADA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 CANADA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 CANADA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 CANADA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 146 CANADA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 147 CANADA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 CANADA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 CANADA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 150 CANADA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 CANADA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 CANADA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 CANADA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 CANADA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 155 CANADA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 CANADA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 CANADA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 CANADA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 CANADA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 CANADA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 161 MEXICO LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 162 MEXICO SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 MEXICO SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 164 MEXICO SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 165 MEXICO KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 MEXICO STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 MEXICO CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 MEXICO DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 169 MEXICO DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 MEXICO DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 171 MEXICO DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 172 MEXICO LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 173 MEXICO LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 MEXICO HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 MEXICO HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 MEXICO ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 MEXICO FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 MEXICO HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 MEXICO TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 MEXICO LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 MEXICO HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 MEXICO PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 MEXICO PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 MEXICO HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 185 MEXICO TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 MEXICO TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 MEXICO TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 MEXICO DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 MEXICO SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 190 MEXICO REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 MEXICO AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 MEXICO PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 MEXICO ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 194 MEXICO LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 195 MEXICO RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA LIPID PANEL TESTING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA LIPID PANEL TESTING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA LIPID PANEL TESTING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 NORTH AMERICA LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD
FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LIPID PANEL TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA LIPID PANEL TESTING MARKET
FIGURE 14 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022
FIGURE 15 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE
FIGURE 18 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022
FIGURE 19 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA LIPID PANEL TESTING MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA LIPID PANEL TESTING MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA LIPID PANEL TESTING MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA LIPID PANEL TESTING MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)
FIGURE 39 NORTH AMERICA LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
